{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T19:49:33Z","timestamp":1786391373095,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2006,10,17]],"date-time":"2006-10-17T00:00:00Z","timestamp":1161043200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Spinal Cord"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1038\/sj.sc.3101982","type":"journal-article","created":{"date-parts":[[2006,10,18]],"date-time":"2006-10-18T07:47:57Z","timestamp":1161157677000},"page":"551-562","source":"Crossref","is-referenced-by-count":53,"title":["The treatment of spasticity with \u03949-tetrahydrocannabinol in persons with spinal cord injury"],"prefix":"10.1038","volume":"45","author":[{"given":"U","family":"Hagenbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Luz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Ghafoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Grotenhermen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Brenneisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"M\u00e4der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,10,17]]},"reference":[{"key":"BF3101982_CR1","unstructured":"Mechoulam R . The pharmacohistory of Cannabis sativa. In: Mechoulam R (ed). Cannabinoids as Therapeutic Agents. CRC Press: Boca Raton."},{"key":"BF3101982_CR2","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0140-6736(02)18723-X","volume":"1","author":"JR Reynolds","year":"1890","unstructured":"Reynolds JR . Therapeutic uses and toxic effects of Cannabis indica. Lancet 1890; 1: 637\u2013638.","journal-title":"Lancet"},{"key":"BF3101982_CR3","first-page":"175","volume":"12","author":"M Dunn","year":"1974","unstructured":"Dunn M, Davis R . The perceived effects of marijuana on spinal cord injured males. Paraplegia 1974; 12: 175.","journal-title":"Paraplegia"},{"key":"BF3101982_CR4","first-page":"116","volume":"63","author":"J Malec","year":"1982","unstructured":"Malec J, Harvey RF, Cayner JJ . Cannabis effect on spasticity in spinal cord injury. Arch Phys Med Rehabil 1982; 63: 116\u2013118.","journal-title":"Arch Phys Med Rehabil"},{"key":"BF3101982_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000112901","volume":"38","author":"P Consroe","year":"1997","unstructured":"Consroe P, Musty R, Rein J, Tillery W, Pertwee R . The perceived effects of smoked cannabis on patients with multiple sclerosis. Eur Neurol 1997; 38: 44\u201348.","journal-title":"Eur Neurol"},{"key":"BF3101982_CR6","first-page":"64","volume-title":"1998 Symposium on the Cannabinoids","author":"P Consroe","year":"1998","unstructured":"Consroe P, Tillery W, Rein J, Musty RE . Reported marijuana effects in patients with spinal cord injury. 1998 Symposium on the Cannabinoids. International Cannabinoid Research Society: Burlington 1998, p 64."},{"key":"BF3101982_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0033-3182(80)73129-8","volume":"21","author":"DJ Petro","year":"1980","unstructured":"Petro DJ . Marijuna as a therapeutic agent for muscle spasm or spasticity. Psychosomatics 1980; 21: 81\u201385.","journal-title":"Psychosomatics"},{"key":"BF3101982_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/BF00314410","volume":"236","author":"HM Meinck","year":"1989","unstructured":"Meinck HM, Conrad B . Effect of cannabinoids on spasticity and ataxia in multiple sclerosis. J Neurol 1989; 236: 120\u2013122.","journal-title":"J Neurol"},{"key":"BF3101982_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/j.1552-4604.1981.tb02621.x","volume":"21","author":"DJ Petro","year":"1981","unstructured":"Petro DJ, Ellenberger C . Treatment of human spasticity with \u03949-tetrahydrocannabinol. J Clin Pharmacol 1981; 21: 413\u2013416.","journal-title":"J Clin Pharmacol"},{"key":"BF3101982_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1300\/J251v07n01_04","volume":"7","author":"JT Ungerleider","year":"1987","unstructured":"Ungerleider JT, Andyrsiak T, Fairbanks L, Ellison GW, Myers LW . \u03949-THC in the treatment of spasticity associated with multiple sclerosis. Adv Alcohol Subst Abuse 1987; 7: 39\u201350.","journal-title":"Adv Alcohol Subst Abuse"},{"key":"BF3101982_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02190083","volume":"240","author":"M Maurer","year":"1990","unstructured":"Maurer M, Henn V, Dittrich A, Hofmann A . Delta-9-tetrahydrocannabinol shows anti-spastic and analgesic effects in a single case double-blind trial. Eur Arch Psychiat Clin Neurosci 1990; 240: 1\u20134.","journal-title":"Eur Arch Psychiat Clin Neurosci"},{"key":"BF3101982_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0140-6736(95)90485-9","volume":"345","author":"CN Martyn","year":"1995","unstructured":"Martyn CN, Illis LS, Thom J . Nabilone in the treatment of multiple sclerosis. Lancet 1995; 345: 579.","journal-title":"Lancet"},{"key":"BF3101982_CR13","first-page":"446","volume":"34","author":"R Brenneisen","year":"1996","unstructured":"Brenneisen R, Egli A, Elsohly MA, Henn V, Spiess Y . The effect of orally and rectally administered delta-9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients. Int J Clin Pharmacol Ther 1996; 34: 446\u2013452.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"BF3101982_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","volume":"42","author":"F Grotenhermen","year":"2003","unstructured":"Grotenhermen F . Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokin 2003; 42: 327\u2013360.","journal-title":"Clin Pharmacokin"},{"key":"BF3101982_CR15","first-page":"73","volume-title":"Cannabis and Cannabinoids. Pharmacology, Toxicology, and Therapeutic Potential","author":"RG Pertwee","year":"2002","unstructured":"Pertwee RG . Sites and mechanisms of action. In: Grotenhermen F, Russo E (eds). Cannabis and Cannabinoids. Pharmacology, Toxicology, and Therapeutic Potential. Haworth Press: Binghamton NY 2002, pp 73\u201387."},{"key":"BF3101982_CR16","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0024-3205(99)00293-3","volume":"65","author":"MC Sa\u00f1udo-Pe\u00f1a","year":"1999","unstructured":"Sa\u00f1udo-Pe\u00f1a MC, Tsou K, Walker JM . Motor actions of cannabinoids in the basal ganglia output nuclei. Life Sci 1999; 65: 703\u2013713.","journal-title":"Life Sci"},{"key":"BF3101982_CR17","first-page":"CD001131","volume":"2","author":"M Tarrico","year":"2000","unstructured":"Tarrico M, Adone R, Pagliacci C, Telaro E . Pharmacological interventions for spasticity following spinal cord injury (Cochrane Review). Cochrane Database Syst Rev 2000; 2: CD001131.","journal-title":"Cochrane Database Syst Rev"},{"key":"BF3101982_CR18","unstructured":"Shakespeare DT, Boggild M, Young C . Anti-spasticity agents for multiple sclerosis. Cochrane Database Syst Rev 2001; 4: CD001332."},{"key":"BF3101982_CR19","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/S0140-6736(03)14738-1","volume":"362","author":"J Zajicek","year":"2003","unstructured":"Zajicek J et al. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet 2003; 362: 1517\u20131526.","journal-title":"Lancet"},{"issue":"Suppl 2","key":"BF3101982_CR20","first-page":"115","volume":"10","author":"J Zajicek","year":"2004","unstructured":"Zajicek J . The cannabinoids in MS study \u2013 final results from 12 months follow-up. Mult Scler 2004; 10 (Suppl 2): 115.","journal-title":"Mult Scler"},{"key":"BF3101982_CR21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1191\/1352458504ms1048oa","volume":"10","author":"C Vaney","year":"2004","unstructured":"Vaney C et al. Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study. Mult Scler 2004; 10: 417\u2013424.","journal-title":"Mult Scler"},{"key":"BF3101982_CR22","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1191\/1352458504ms1082oa","volume":"10","author":"DT Wade","year":"2004","unstructured":"Wade DT, Makela P, Robson P, House H, Bateman C . Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. Mult Scler 2004; 10: 434\u2013441.","journal-title":"Mult Scler"},{"key":"BF3101982_CR23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/ptj\/67.2.206","volume":"67","author":"RW Bohannon","year":"1987","unstructured":"Bohannon RW, Smith MB . Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67: 206\u2013207.","journal-title":"Phys Ther"},{"key":"BF3101982_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/00002060-199304000-00005","volume":"72","author":"CV Granger","year":"1993","unstructured":"Granger CV, Hamilton BB, Linacre JM, Heinemann AW, Wright BD . Performance profiles of the functional independence measure. Arch Phys Rehabil 1993; 72: 84\u201389.","journal-title":"Arch Phys Rehabil"},{"key":"BF3101982_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M . A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"BF3101982_CR26","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/1097-4679(199507)51:4<548::AID-JCLP2270510414>3.0.CO;2-Q","volume":"51","author":"DB Baker","year":"1995","unstructured":"Baker DB, Taylor CJ, Leyva C . Continious performance tests: a comparison of modalities. J Clin Psychol 1995; 51 (4): 548\u2013551.","journal-title":"J Clin Psychol"},{"key":"BF3101982_CR27","volume-title":"Actualit\u00e9s pedagogiques et psychologique","author":"R Zazzo","year":"1974","unstructured":"Zazzo R . Test de deux barrages. Actualit\u00e9s pedagogiques et psychologique Vol. 7. Delachaux et Nestl\u00e9: Neuch\u00e2tel 1974."},{"key":"BF3101982_CR28","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1212\/WNL.58.9.1404","volume":"58","author":"J Killestein","year":"2002","unstructured":"Killestein J et al. Safety, tolerability, and efficacy of orally administered cannabinoids in MS. Neurology 2002; 58: 1404\u20131407.","journal-title":"Neurology"},{"key":"BF3101982_CR29","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2165\/00023210-199911050-00001","volume":"11","author":"RG Pertwee","year":"1999","unstructured":"Pertwee RG . Prescribing cannabinoids for multiple sclerosis. CNS Drugs 1999; 11: 327\u2013334.","journal-title":"CNS Drugs"},{"key":"BF3101982_CR30","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/ana.410130616","volume":"13","author":"DB Clifford","year":"1983","unstructured":"Clifford DB . Tetrahydrocannabinol for tremor in multiple sclerosis. Ann Neurol 1983; 13: 669\u2013671.","journal-title":"Ann Neurol"},{"key":"BF3101982_CR31","unstructured":"Helwig S, Fronk EM, Reif M, Schnelle M, Hoffmann J . Maximally tolerated dose (mtd) of standardized cannabis extract in palliative cancer patients: preliminary results from an open label, on-randomized phase I\/II trial. Second Conference on Cannabis and Cannabinoids International Association Cannabis as Medicine, Cologne, September 12\u201313, 2003."},{"key":"BF3101982_CR32","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/00045391-199510000-00012","volume":"2","author":"RW Kogel","year":"1995","unstructured":"Kogel RW, Johnson PB, Chintam R, Robinson CHJ, Nemchausky BA . Treatment of spasticity in spinal cord injury with dronabinol, a tetrahydrocannabinol derivate. Am J Ther 1995; 2: 799\u2013805.","journal-title":"Am J Ther"},{"key":"BF3101982_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1191\/1352458503ms929oa","volume":"9","author":"A Riazi","year":"2003","unstructured":"Riazi A, Fox P, Vickery J, Thompson AJ, Zajicek J, Hobart JC . Developing a patient-based measure of the impact of spasticity in multiple sclerosis. Mult Scler 2003; 9: 151.","journal-title":"Mult Scler"},{"key":"BF3101982_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/BF00319679","volume":"238","author":"J Noth","year":"1991","unstructured":"Noth J . Trends in the pathophysiology and pharmacotherapy of spasticity. J Neurol 1991; 238: 131\u2013139.","journal-title":"J Neurol"},{"key":"BF3101982_CR35","volume-title":"Manter and Gatz's Essentials of Clinical Neuroanatomy and Neurophysiology","author":"S Gilman","year":"1996","unstructured":"Gilman S, Newman SW (eds). Manter and Gatz's Essentials of Clinical Neuroanatomy and Neurophysiology 9th edn. Philadelphia: FA Davis Company 1996."},{"key":"BF3101982_CR36","first-page":"195","volume-title":"Cannabis and Cannabinoids. Pharmacology, Toxicology, and Therapeutic Potential","author":"RE Musty","year":"2002","unstructured":"Musty RE, Consroe P . Spastic Disorders. In: Grotenhermen F, Russo E (eds). Cannabis and Cannabinoids. Pharmacology, Toxicology, and Therapeutic Potential. Haworth Press: Binghamton NY 2002, pp 195\u2013197."},{"key":"BF3101982_CR37","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1096\/fj.00-0399fje","volume":"15","author":"D Baker","year":"2001","unstructured":"Baker D et al. Endocannabinoids control spasticity in a multiple sclerosis model. FASEB J 2001; 15: 300\u2013302.","journal-title":"FASEB J"},{"key":"BF3101982_CR38","first-page":"18","volume":"17","author":"DT Wade","year":"2003","unstructured":"Wade DT, Robson P, House H, Makela P, Aram J . A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. Clin Rehabil 2003; 17: 18\u201326.","journal-title":"Clin Rehabil"},{"key":"BF3101982_CR39","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1191\/1352458504ms1063oa","volume":"10","author":"CM Brady","year":"2004","unstructured":"Brady CM, DasGupta R, Dalton C, Wiseman OJ, Berkely KJ, Fowler CJ . An open label pilot study of cannabis-based extracts for bladder dysfunction in advanced muliple sclerosis. Mult Scler 2004; 10: 425\u2013433.","journal-title":"Mult Scler"},{"key":"BF3101982_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1055\/s-2001-15191","volume":"34","author":"KR M\u00fcller-Vahl","year":"2001","unstructured":"M\u00fcller-Vahl KR, Koblenz A, Jobges M, Kolbe H, Emrich HM, Schneider U . Influence of treatment of Tourette syndrome with delta9-tetrahydrocannabinol (delta9-THC) on neuropsychological performance. Pharmacopsychiatry 2001; 34: 19\u201324.","journal-title":"Pharmacopsychiatry"},{"key":"BF3101982_CR41","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1136\/bmj.38149.566979.AE","volume":"329","author":"KB Svendsen","year":"2004","unstructured":"Svendsen KB, Jensen TS, Bach FW . Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. BMJ 2004; 329: 253\u2013260.","journal-title":"BMJ"},{"key":"BF3101982_CR42","doi-asserted-by":"crossref","unstructured":"Young CA, Rog DJ . Randomised controlled trial of cannabis based medicinal extracts (CBME) in central neuropathic pain due to multiple sclerosis. IV. Congress of the European Federation of IASP Chapters (EFIC) September 2\u20136, 2003, Prag.","DOI":"10.1016\/j.jpain.2005.01.147"},{"key":"BF3101982_CR43","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.pain.2004.09.013","volume":"112","author":"JS Berman","year":"2004","unstructured":"Berman JS, Symonds C, Birch R . Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial. Pain 2004; 112: 299\u2013306.","journal-title":"Pain"},{"key":"BF3101982_CR44","unstructured":"Abrams DI et al. The effects of smoked cannabis in painful peripheral neuropathy and cancer pain refractory to opioids. IACM 2nd Conference on Cannabinoids in Medicine Cologne, September 12\u201313, 2003."},{"key":"BF3101982_CR45","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S1090-3801(03)00084-3","volume":"8","author":"N Attal","year":"2004","unstructured":"Attal N, Brasseur L, Guirimand D, Clermond-Gnamien S, Atlami S, Bouhassira D . Are oral cannabinoids safe and effective in refractory neuropathic pain? Eur J Pain 2004; 8: 173\u2013177.","journal-title":"Eur J Pain"},{"issue":"8\u20139 Suppl","key":"BF3101982_CR46","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/j.1552-4604.1981.tb02608.x","volume":"21","author":"WC Clark","year":"1981","unstructured":"Clark WC, Janal MN, Zeidenberg P, Nahas GG . Effects of moderate and high doses of marihuana on thermal pain: a sensory decision theory analysis. J Clin Pharmacol 1981; 21 (8\u20139 Suppl): 299\u2013310.","journal-title":"J Clin Pharmacol"},{"key":"BF3101982_CR47","first-page":"415","volume":"188","author":"SY Hill","year":"1974","unstructured":"Hill SY, Schwin R, Goodwin DW, Powell B . Marihuana and pain. J Pharmacol Exp Ther 1974; 188: 415\u2013418.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF3101982_CR48","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0304-3959(03)00163-5","volume":"105","author":"M Naef","year":"2003","unstructured":"Naef M, Curatolo M, Petersen-Felix S, Arendt-Nielsen L, Zbinden A, Brenneisen R . The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions. Pain 2003; 105: 79\u201388.","journal-title":"Pain"},{"key":"BF3101982_CR49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/cpt197721126","volume":"21","author":"D Raft","year":"1977","unstructured":"Raft D, Gregg J, Ghia J, Harris L . Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Psychological correlates of the analgesic response. Clin Pharmacol Ther 1977; 21: 26\u201333.","journal-title":"Clin Pharmacol Ther"},{"key":"BF3101982_CR50","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/cpt1978242223","volume":"24","author":"PR Jochimsen","year":"1978","unstructured":"Jochimsen PR, Lawton RL, VerSteeg K, Noyes Jr R . Effect of benzopyranoperidine, a delta-9-THC congener, on pain. Clin Pharmacol Ther 1978; 24: 223\u2013227.","journal-title":"Clin Pharmacol Ther"},{"key":"BF3101982_CR51","first-page":"885","volume":"118","author":"CW Zwillich","year":"1978","unstructured":"Zwillich CW, Doekel R, Hammill S, Weil JV . The effects of smoked marijuana on metabolism and respiratory control. Am Rev Respir Dis 1978; 118: 885\u2013891.","journal-title":"Am Rev Respir Dis"}],"container-title":["Spinal Cord"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/3101982.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3101982","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3101982.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:49:21Z","timestamp":1684284561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3101982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,17]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["BF3101982"],"URL":"https:\/\/doi.org\/10.1038\/sj.sc.3101982","relation":{},"ISSN":["1362-4393","1476-5624"],"issn-type":[{"value":"1362-4393","type":"print"},{"value":"1476-5624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,17]]}}}